PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 187 filers reported holding PDL BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 2.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $0 | – | 206 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 206 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 206 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 206 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 206 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 206 | -47.6% | 0.00% | – |
| Q3 2017 | $1,000 | – | 393 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 393 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 393 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 393 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 393 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | -80.0% | 393 | -76.7% | 0.00% | – |
| Q1 2016 | $5,000 | +400.0% | 1,687 | +358.4% | 0.00% | – |
| Q4 2015 | $1,000 | -50.0% | 368 | -21.4% | 0.00% | – |
| Q3 2015 | $2,000 | -98.8% | 468 | -97.8% | 0.00% | -100.0% |
| Q3 2009 | $166,000 | 0.0% | 21,090 | 0.0% | 0.03% | -12.8% |
| Q2 2009 | $166,000 | +11.4% | 21,090 | 0.0% | 0.04% | -7.1% |
| Q1 2009 | $149,000 | +14.6% | 21,090 | 0.0% | 0.04% | +27.3% |
| Q4 2008 | $130,000 | -33.7% | 21,090 | 0.0% | 0.03% | -13.2% |
| Q3 2008 | $196,000 | – | 21,090 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |